Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Biocept, Inc.

TRADE

NASDAQ: BIOCHealthcare / Medical Laboratories & Research / USA
2.84-0.08-2.74%Vol 181 1971Y Perf -92.30%
Sep 25th, 2018 16:00
BID2.83 ASK2.84
Open3.00 Previous Close2.92
Pre-Market- After-Trading2.83
 - -%  -0.01 -0.35%
Target Price
19.52 
Analyst Rating
Moderate Buy 2.00
Potencial %
587.32 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★+     48.57
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)6 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
0.03 
Earnings Date
8th Nov 2018

Today's Price Range

2.833.06

 

52wk Range

2.8340.50

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-11.53%
3 Months
1 252.38%
6 Months
816.13%
1 Year
-92.30%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
BIOC2.84-0.0800-2.74
AAPL222.191.40000.63
GOOG1 184.6511.28000.96
MSFT114.45-0.2200-0.19
XOM86.50-0.1000-0.12
WFC54.23-0.0300-0.06
JNJ138.64-1.8300-1.30
FB164.91-0.5000-0.30
GE11.27-0.4700-4.00
JPM116.39-0.3300-0.28
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.90
Current Ratio 1.20
Long Term Debt to Total Capital 0.30
Total Debt to Equity 0.68
Interest Coverage -94.80
Leverage Ratio 2.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-167.20
EBIT Margin-634.10
EBITDA Margin-615.20
Pre-tax Profit Margin-4 508.80
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.65
PS Ratios 1.80
Price to Cash Flow -
Price to Free Cash Flow -0.30
Cash Flow Per Share -14.27
Price to Tangible Book2.65
Book Value per Share1.11
Enterprise Value (in ths.)5 867
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)471.09
ROE last 12 Months -478.22
Return on Assets (5Y Avg) -142.42
ROA last 12 Months -206.20
Return on Capital (5Y Avg) -
ROC last 12 Months -340.99
Return on invested Capital Q -80.70
Return on invested Capital Y-492.25
Assets Turnover0.40
Receivables Turnover4.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)3 736
Revenue per Share 1.64
Revenue Growth 3 Years 115.19
Revenue Growth 5 Years 126.13
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-3.30-2.7018.18
Q01 2018-2.10-3.30-57.14
Q04 2017-5.71-5.415.25
Q03 2017-5.71-6.01-5.25
Q02 2017-6.01-6.31-4.99
Q01 2017-6.61-6.314.54
Q04 2016-0.34-0.2720.59
Q03 2016-0.57-0.570.00
Earnings Per EndEstimateRevision %Trend
9/2018 QR-2.400.00-
12/2018 QR-1.500.00-
12/2018 FY-9.010.00-
12/2019 FY-5.410.00-
Next Report Date8th Nov 2018
Estimated EPS Next Report-2.40
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume181 197
Shares Outstanding (in ths.)2 270
Trades Count479
Dollar Volume468 923
Avg. Volume226 415
Avg. Weekly Volume221 040
Avg. Monthly Volume152 625
Avg. Quarterly Volume527 226

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

25%75%

Bearish Bullish

62%38%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

There are no comments yet.

News

x